Advertisement

Topics

Cue Biopharm, Inc. Company Profile

08:50 EDT 19th June 2018 | BioPortfolio


News Articles [35 Associated News Articles listed on BioPortfolio]

Janssen to acquire BeneVir Biopharm for up to $1bn

Johnson & Johnson subsidiary Janssen Biotech has signed a definitive agreement to buy biotechnology company BeneVir Biopharm for a total...Read More... The post Janssen to acquire BeneVir Biopharm...

Johnson & Johnson Acquire BeneVir Biopharm

NewsJanssen will gain Benevir Biopharm's oncolytic immunotherapy platform in the acquisition.

TC BioPharm, Scotia Biologics partner for cancer drug R&D

Biotechnology company TC BioPharm and Scotia Biologics agreed to work together to develop therapies for cancer and major vira -More- 

J&J Janssen arm to Buy Benevir Biopharm

BeneVir Biopharm, a privately-held biotechnology company in the life science portfolio of the HC2 holding, will be bought by Janssen Biotech, a subsidiary of Johnson & Johnson under a recently sig...

Janssen Biotech to buy BeneVir Biopharm in $1bn deal

Janssen Biotech has agreed to acquire US-based BeneVir Biopharm, a biopharmaceutical company focused on developing oncolytic immunotherapies for cancer, in a deal worth $1.04bn.

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens

HORSHAM, Pa., May 2, 2018 /PRNewswire/ — Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has entered into a definitive agreem...

Scottish Biotech Boosts its CAR-T Pipeline for Cancer and HIV

TC Biopharm has partnered with Scotia Biologics to produce tumor-specific antibodies for a new generation of safer CAR-T therapies against multiple types of tumors as well as viral infections such as ...

TC Biopharm gets €4m Horizon2020 grant

Drugs and Medications [0 Results]

None

Clinical Trials [0 Results]

None

Companies [33 Associated Companies listed on BioPortfolio]

BioPharm Services US

BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...

R-Biopharm Inc.

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...

TTY Biopharm

TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.

Biopharm

Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...

BioPharm Insight

BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousa...

More Information about "Cue Biopharm, Inc." on BioPortfolio

We have published hundreds of Cue Biopharm, Inc. news stories on BioPortfolio along with dozens of Cue Biopharm, Inc. Clinical Trials and PubMed Articles about Cue Biopharm, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cue Biopharm, Inc. Companies in our database. You can also find out about relevant Cue Biopharm, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record